ULBP3: A Potential Drug Target and Biomarker (G79465)

Target Name: ULBP3

NCBI ID: G79465

ULBP3

ULBP3: A Potential Drug Target and Biomarker

Unlike most proteins, ULBP3 (Unredeemed light chain B-helical protein 3) is not a naturally occurring protein in the human body. Instead, it is a synthetic protein that has been created in the lab using a genetic engineering technique called DNA- protein kinase (DNAPK). This technology allows researchers to create proteins with specific functions, such as ULBP3, that can be used for a variety of applications, including drug development.

ULBP3 is a 16-kDa protein that is expressed in various tissues and cells in the body. It is primarily located in the endoplasmic reticulum (ER), which is the part of the cell that transports and modifies proteins before they are released into the cytoplasm . ULBP3 is involved in the regulation of protein synthesis, which is a critical process that helps cells function properly.

One of the interesting aspects of ULBP3 is its potential as a drug target. Its unique structure and function have led some researchers to believe that it may be a useful target for small molecule inhibitors. This is because ULBP3's kinase domain is known to be sensitive to inhibitors, which could make it an attractive target for drugs that are designed to inhibit protein synthesis.

In addition to its potential as a drug target, ULBP3 has also been identified as a potential biomarker. Its expression is regulated by various factors, including cytokines and growth factors. This makes it a useful marker for tracking the effects of drugs on protein synthesis and cell function.

ULBP3 has also been shown to play a role in the regulation of cellular processes that are important for cancer progression. In fact, studies have suggested that ULBP3 may be a potential therapeutic target for cancer, particularly for the treatment of breast cancer. This is because ULBP3 has been shown to be involved in the regulation of cell cycle progression, which is a critical process that is altered in many types of cancer.

In conclusion, ULBP3 is a synthetic protein that has been created using DNA-protein kinase technology. Its unique structure and function have led some researchers to believe that it may be a potential drug target and biomarker. Further research is needed to fully understand its potential applications in medicine.

Protein Name: UL16 Binding Protein 3

Functions: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity

The "ULBP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ULBP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets